Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED) - 6 months ended Jun. 30, 2017 - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated (Deficit)
Total
Beginning Balance, Shares at Dec. 31, 2016 73,509,663      
Beginning Balance, Amount at Dec. 31, 2016 $ 73,510 $ 49,838,469 $ (54,883,223) $ (4,971,244)
Stock and warrants issued upon debt conversion, Shares 51,236      
Stock and warrants issued upon debt conversion, Amount $ 51 25,567 25,618
Stock issued upon cashless warrant exercise, Shares 630,214      
Stock issued upon cashless warrant exercise, Amount $ 630 230,347 230,977
Stock issued per settlement agreement, Shares 130,000      
Stock issued per settlement agreement, Amount $ 130 60,970 61,100
Stock issued for the acquisition of patents rights, Shares 925,000      
Stock issued for the acquisition of patents rights, Amount $ 925 517,075 518,000
Issuance of stock options 1,236,783 1,236,783
Net loss (773,813) (773,813)
Ending Balance, Shares at Jun. 30, 2017 75,246,113      
Ending Balance, Amount at Jun. 30, 2017 $ 75,246 $ 51,909,211 $ (55,657,036) $ (3,672,579)